EC Healthcare's Chairman Eddy Tang Further Increases Shareholdings With Strong Confidence in the Group's Future Development
HONG KONG, Mar 09, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group's Chairman, Executive Director and Chief Executive Officer Mr. Tang Chi Fai ("Mr. Tang") acquired a total 1,000,000 shares of the Company on the market for an aggregate consideration of approximately HK$ 7.246 million at an average price of HK$7.2465 per Share. Prior to this transaction, Mr. Tang had already increased shareholdings 3 times this year with a total of 1.15 million increased shares and the average price was $9.194, $8.49 & $8.18 per share. After the transaction, Mr. Tang is interested in an aggregate of 721,927,610 Shares and his equity stake in the Group increased from 61.18% to 61.26%
In the past year, EC Healthcare has actively integrated the healthcare market through organic growth and acquisitions to further consolidate leading market position. As the epidemic has raged on in Hong Kong now, the Group also actively provides anti-epidemic medical services to the public through its general outpatient clinics, specialist clinics, health check centers, vaccine centers and laboratory centers. Looking forward, the Group remain confident for the long-term strong business growth momentum and will keep investing in IT, brand and service to provide better services to the public.
About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.
The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL, NEW MEDICAL CENTER and Prime Medical Centres, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.
*According to independent research conducted by Frost and Sullivan in terms of revenue in 2019 and 2020
For further information, please contact: iPR Ogilvy Limited Callis Lau / Lorraine Luk / Charmaine Ip Tel: (852) 2136 6952 / 2169 0467 / 3920 7649 Fax: (852) 3170 6606 Email: ech@iprogilvy.com
Source: EC Healthcare Sectors: BioTech, Healthcare & Pharm
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 Mitsubishi Motors to Launch an All-New BEV Based on Nissan's Next-Generation LEAF in North America in the Second Half of 2026 May 08, 2025 11:25 JST
|  Mitsubishi Motors and Foxtron Sign MOU for OEM Supply of EV May 08, 2025 11:08 JST
|  Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China May 07, 2025 19:06 JST
|  Anime Tokyo Station: Mobile Suit Gundam GQuuuuuuX -Beginning- Special Exhibition May 03, 2025 03:00 JST
|  TOYOTA GAZOO Racing Set for Spa spectacle May 02, 2025 19:29 JST
|  FWD Group reports exceptionally strong first quarter new business update May 02, 2025 17:00 JST
|  Toyota Mobility Foundation, Bangkok Metropolitan Administration, UN-Habitat, Asian Institute of Technology and Toyota Motor Thailand Sign a Letter of Intent (LOI) to Launch the TRUST Project for Road Safety in Thailand May 01, 2025 17:48 JST
|  Katalon Officially Launches TrueTest(TM) - The First AI-Native Testing System That Thinks Like a Tester and Learns from Users Apr 30, 2025 17:20 JST
|  Eisai Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star Apr 30, 2025 14:17 JST
|  Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of Large Car Ferry KEYAKI in Shimonoseki Apr 29, 2025 17:24 JST
|  NEC DGDF Headquarters relocates to Zurich to accelerate growth and enhance management globally Apr 28, 2025 16:03 JST
| NEC achieves Japan's longest terrestrial wireless optical communication over 10 km Apr 25, 2025 17:50 JST
|  Olympus Appoints New CEO Apr 25, 2025 15:30 JST
|  DENSO Announces Year-End Financial Results Apr 25, 2025 12:17 JST
|  DENSO and DELPHY Sign Memorandum of Understanding to Develop Data-Driven Smart Horticulture Apr 24, 2025 18:43 JST
|  MyJCB App Wins "iF DESIGN AWARD 2025" Apr 24, 2025 17:00 JST
|  Fujitsu launches new company 1FINITY to strengthen network products business
Apr 24, 2025 16:24 JST
|  MHIEC Completes Renovation of Core Facilities for Arita Municipal Recycle Plaza in Saga Prefecture Apr 24, 2025 15:01 JST
|  NEC invests in U.S.-based "Geodesic Alliance Fund" aiming to strengthen economic security business Apr 24, 2025 10:23 JST
|  MHI Thermal Systems Wins German Red Dot Design Award 2025 Apr 24, 2025 10:11 JST
|
More Latest Release >>
|